- Exhibit & Support
- Hotel & Travel
Finally—cardiovascular disease (CV) is becoming more manageable. However, as evidence-based therapies emerge to reduce CV events, including mortality, selecting the appropriate therapy for patients is still a challenge. Health care providers can reference the 2017 American College of Cardiology and National Lipid Association evidence-based, patient-centered recommendations for management of dyslipidemia. Attend this expert-led session to learn how to lower atherosclerotic cardiovascular disease (ASCVD), the role of nonstatin therapies in ASCVD risk reduction, and how to identify patients who may be appropriate for treatment.
This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit..
At the completion of this application-based activity, participants will be able to: